| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |